STAT3 and graft versus host disease: As judged by percentage of body weight changes, clinical GVHD score, survival, and histopathology, the severity of acute GVHD did not differ between recipients given STAT3-S727A T or WT T cells (Figure 9B and Supplemental Figure 15).